ClinicalTrials.gg
Sign In
CompletedNCT05758051SCFEUpdated Mar 7, 2023

Management of Slipped Capital Femoral Epiphysis (SCFE) on Top of Fixed Fracture Neck of Femur Case Report.

An interventional study of subtrochanteric valgus osteotomy in Slipped Capital Femoral Epiphysis, sponsored by Assiut University. Completed at 1 site in Egypt. Open to male participants aged 3 Years to 14 Years. Per ClinicalTrials.gov, last updated 2023-03-07.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Jan 2022, registered Feb 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Not applicable
Ages
3 Years to 14 Years
Sex
Male
01

Study summary

Slipped Capital Femoral Epiphysis (SCFE) on Top of Fixed Fracture Neck of Femur managed by subtrochanteric valgus osteotomy

Read the detailed description

The incidence of Slipped capital femoral epiphysis (SCFE) after management of femoral neck fracture in pediatrics is very rare. In this case report, a 9-year-old female child sustained left sided femur neck fracture after a motor car accident. The fracture was fixed by two cannulated screws and healing with mild varus occurred after 1.5 months. However, progressive slippage of femoral epiphysis was observed. This was treated by subtrochanteric valgus osteotomy

02

Conditions studied

  • Slipped Capital Femoral Epiphysis

Keywords

  • Slipped capital femoral epiphysis
  • SCFE
  • coxa vara
  • fracture neck of femur
03

In context

Slipped Capital Femoral Epiphyses

19 studies on the registry are indexed under Slipped Capital Femoral Epiphyses; 2 are open to participants now.

This study's enrollment of 1 is below the median of 143 across 14 interventional studies indexed under Slipped Capital Femoral Epiphyses.

Browse Slipped Capital Femoral Epiphyses studies →

Lead sponsor

Assiut University is the lead sponsor of 5,081 studies on the registry; 2,179 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Assiut University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 14 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scfe on top NOF

Exclusion criteria

Exclusion Criteria:

  • pathological fracture
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1 participant (actual)

Study arms

  • Other
    subtrochanteric valgus osteotomy

    subtrochanteric valgus osteotomy

    Procedure: subtrochanteric valgus osteotomy

Interventions

  • Proceduresubtrochanteric valgus osteotomy

    subtrochanteric valgus osteotomy

06

What researchers measure

Primary outcomes

  1. modified McKay's criteria

    I excellent II Good III Fair IV Poor

    Time frame: one year

Secondary outcomes

  1. Rust union score

    union 1. absent callus visible fracture 2. present callus visible fracture 3. present callus invisible fracture

    Time frame: one year

07

Study locations

1 site
  • faculty of medicine Assiut university
    Assiut, 71515, Egypt
08

References and documents

Publications

  • Yerli M, Ocak O, Yuce A, Bayraktar TO, Kir MC, Imren Y, Dedeoglu SS, Gurbuz H. Retrospective analysis of 35 pediatric femoral neck fractures. Eur J Orthop Surg Traumatol. 2022 Oct;32(7):1385-1390. doi: 10.1007/s00590-021-03126-6. Epub 2021 Sep 20. PubMed 34542716 ↗
  • Li H, Zhao L, Huang L, Kuo KN. Delayed Slipped Capital Femoral Epiphysis After Treatment of Femoral Neck Fracture in Children. Clin Orthop Relat Res. 2015 Aug;473(8):2712-7. doi: 10.1007/s11999-014-4067-y. Epub 2014 Nov 27. PubMed 25427426 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2022 to primary completion in Jan 2023, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2023
First posted
Mar 7, 2023
StartActual
Jan 1, 2022
Primary completionActual
Jan 1, 2023
CompletionActual
Jan 1, 2023
Last update
Mar 7, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05758051
Lead sponsor
Assiut University
Responsible party
Hesham Mohamed Elbaseet (Principal investigator, Assiut University) — Principal investigator
First posted
Mar 7, 2023
Start date
Jan 1, 2022
Primary completion
Jan 1, 2023
Completion
Jan 1, 2023
Last update
Mar 7, 2023

Study contacts

Hesaham M Elbaseet, MD
principal investigator · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Slipped Capital Femoral Epiphyses →

Other studies from this sponsor

Assiut University →

Start the discussion